tradingkey.logo

Zentalis Pharmaceuticals Provides Corporate Update

ReutersJan 6, 2026 1:59 PM

- Zentalis Pharmaceuticals Inc ZNTL.O:

  • ZENTALIS PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND HIGHLIGHTS KEY MILESTONES AND EXPECTED MOMENTUM IN THE AZENOSERTIB DEVELOPMENT PROGRAM FOR 2026

  • ZENTALIS PHARMACEUTICALS INC - DENALI PART 2 TOPLINE READOUT EXPECTED BY YEAR END 2026

  • ZENTALIS PHARMACEUTICALS INC - ASPENOVA PHASE 3 TRIAL INITIATION PLANNED IN 1H 2026

  • ZENTALIS PHARMACEUTICALS INC - DENALI PART 2A ENROLLMENT COMPLETED; DOSE CONFIRMATION EXPECTED 1H 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI